The global infectious disease diagnostics market was valued at US$ 21.3 Billion in 2023 and is expected to register a CAGR of 7.7% over the forecast period and reach US$ 41.5 Bn in 2032.

Infectious diseases are not necessarily observable or show signs of presence openly, but are ever-present and an everyday threat to the health and wellness across the global population. Every individual is at some point in the day exposed to some type of infection, and could contract a disease, or ward off potential danger if the immune system is robust or the infection is weakened. However, with surging infection rates and increasing rates of infection, it is critical for proper and accurate testing is conducted, and that the appropriate preventive measures are taken to combat and halt disease and infection spread to safeguard against any catastrophic outcomes and effects.